chr7-140753335-CA-GT
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PM5PP2PP3
The NM_004333.6(BRAF):c.1799_1800delTGinsAC(p.Val600Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V600E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004333.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRAF | NM_001374258.1 | c.1919_1920delTGinsAC | p.Val640Asp | missense_variant | ENST00000644969.2 | NP_001361187.1 | ||
BRAF | NM_004333.6 | c.1799_1800delTGinsAC | p.Val600Asp | missense_variant | ENST00000646891.2 | NP_004324.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRAF | ENST00000644969.2 | c.1919_1920delTGinsAC | p.Val640Asp | missense_variant | NM_001374258.1 | ENSP00000496776.1 | ||||
BRAF | ENST00000646891.2 | c.1799_1800delTGinsAC | p.Val600Asp | missense_variant | NM_004333.6 | ENSP00000493543.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Melanoma Uncertain:1
Uncertain significance, no assertion criteria provided | research | Dave Chen Lab, Washington University School of Medicine | Mar 28, 2023 | Somatic variant identified in a melanoma arising in a patient with Tatton-Brown Rahman Syndrome - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.